In pursuance to Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, Aptus Pharma has informed that it enclosed the Confirmation Certificate as received from Accurate Securities & Registry, Registrar and Share Transfer Agent for the quarter ended on 30th June, 2026.
The above information is a part of company’s filings submitted to BSE.